Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
There has been concern about the use of non-steroidal anti-inflammatory medications (NSAIDs) in relation to Covid-19 following a statement by the French Health Minister (a clinician) advising against the use of ibuprofen.
This statement was based on provisional information reported from French care settings which UK authorities have not seen and are, to date, unpublished. There is no current literature on the impact of NSAIDs use in Covid-19.
NHS England Medical Director Professor Stephen Powis commented:
“There appears to be no evidence that NSAIDs increase the chance of acquiring Covid-19. In view of the current lack of clarity, the Committee of Human Medicines (an advisory body of MHRA) and NICE have been asked to review the evidence.
“It is therefore suggested that, in the interim, for patients, who have confirmed Covid-19 or believe they have Covid-19, that they use paracetamol in preference to NSAIDs.
“Those currently on NSAIDs for other medical reasons (e.g. arthritis) should not stop them.
“This position will be kept under constant review.”
Read the full Scottish Government circular below.
This circular is being shared under the Open Government Copyright licence.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.